Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Alberta

$25,000.00

Ultrasound technology to improve transfection of human cells

FY 2018-19

Summary
Nucleic acid delivery to human cells (so called transfection) is a widely practiced in biomedical research industry and clinical therapy. Human cells are especially resistant to delivery of nucleic acids due to active mechanisms to resist the intake of foreign genetic material. Chemical methods have been the preferred approach to nucleic acid delivery to human cells over viral means of delivery, since they are safe and do not cause integration of nucleic acids into the host cell genome. In chemical delivery methods, nucleic acids are combined with lipidic or polymeric agents in buffers and packaged into particles at the nanoscale so that the nucleic acids are readily internalized upon exposure of the cells. While such nanoparticles were shown to be generally effective in cell lines, the delivery efficiency of the nanoparticles to primary human cells is very low. In order to enhance the delivery efficiency, one may be able to utilize ultrasound, which open up transient pores in the cell membrane and allow passage of molecules into the cells. This project is intended to explore this approach, in which the nucleic acids are first condensed into nanoparticles for cell uptake and then ultrasound is used in order to facilitate the cellular entry of the nanoparticles. Such an approach is expected to enhance the transfection rates in human cells and enable marketing of ultrasound devices for improved transfection of human cells in biomedical research industry. *
Program
Engage Grants Program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
532402-2018
Name nom
Uludag, Hasan
Department département
Chemical and Materials Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Ultrasound technology to improve transfection of human cells
Keyword
NSERC
Application summary
Nucleic acid delivery to human cells (so called transfection) is a widely practiced in biomedical research industry and clinical therapy. Human cells are especially resistant to delivery of nucleic acids due to active mechanisms to resist the intake of foreign genetic material. Chemical methods have been the preferred approach to nucleic acid delivery to human cells over viral means of delivery, since they are safe and do not cause integration of nucleic acids into the host cell genome. In chemical delivery methods, nucleic acids are combined with lipidic or polymeric agents in buffers and packaged into particles at the nanoscale so that the nucleic acids are readily internalized upon exposure of the cells. While such nanoparticles were shown to be generally effective in cell lines, the delivery efficiency of the nanoparticles to primary human cells is very low. In order to enhance the delivery efficiency, one may be able to utilize ultrasound, which open up transient pores in the cell membrane and allow passage of molecules into the cells. This project is intended to explore this approach, in which the nucleic acids are first condensed into nanoparticles for cell uptake and then ultrasound is used in order to facilitate the cellular entry of the nanoparticles. Such an approach is expected to enhance the transfection rates in human cells and enable marketing of ultrasound devices for improved transfection of human cells in biomedical research industry. *